|
GLCCI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.706400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.962000E-01 |
| Normal-vs-Stage2 |
8.582600E-01 |
| Normal-vs-Stage3 |
1.644580E-03 |
| Normal-vs-Stage4 |
9.84149999999628E-05 |
| Stage1-vs-Stage2 |
6.682200E-01 |
| Stage1-vs-Stage3 |
1.926430E-02 |
| Stage1-vs-Stage4 |
4.740000E-03 |
| Stage2-vs-Stage3 |
1.387620E-01 |
| Stage2-vs-Stage4 |
5.685700E-02 |
| Stage3-vs-Stage4 |
4.195000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.311000E-01 |
| Normal-vs-AfricanAmerican |
2.232600E-01 |
| Normal-vs-Asian |
6.420200E-01 |
| Caucasian-vs-AfricanAmerican |
1.074020E-01 |
| Caucasian-vs-Asian |
8.467800E-01 |
| AfricanAmerican-vs-Asian |
5.253400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.833600E-01 |
| Normal-vs-Female |
8.084200E-02 |
| Male-vs-Female |
6.767900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.249000E-01 |
| Normal-vs-Extreme_Weight |
4.343600E-01 |
| Normal-vs-Obese |
8.600000E-01 |
| Normal-vs-Extreme_Obese |
1.862760E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.981400E-01 |
| Normal_Weight-vs-Obese |
4.810800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.858620E-01 |
| Extreme_Weight-vs-Obese |
5.830800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.204180E-01 |
| Obese-vs-Extreme_Obese |
3.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.955600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.292200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.008200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.492320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.765400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.604000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.406400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.422200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.079690E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.437800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.920050E-01 |
| Normal-VS-Type2 PRCC |
3.466100E-02 |
| Normal-VS-KIRP CIMP |
1.976070E-03 |
| Normal-VS-Unclassified PRCC |
9.087200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.189740E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.515140E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.545800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.625200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.291600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.460100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.424700E-03 |
| Normal-vs-N1 |
3.517400E-03 |
| Normal-vs-N2 |
1.972110E-02 |
| N0-vs-N1 |
5.625200E-01 |
| N0-vs-N2 |
6.834400E-01 |
| N1-vs-N2 |
8.664400E-01 |
|
|
